Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017
Yunfei Jia(Xi'an University of Science and Technology), George F. Gao(Chinese Academy of Sciences), Pu Han(Chinese Academy of Sciences), Yu Hu(University of Science and Technology of China), Anqi Zheng(Peking University), Wen‐xia Tian(Shanxi Agricultural University), Qihui Wang(Shanxi Agricultural University), Sheng Niu(Shanxi Agricultural University), Zhihai Chen(Capital Medical University), Di Tian(Capital Medical University), Pengcheng Han(Zhongda Hospital Southeast University), Chao Su(City University of Hong Kong), Jianxun Qi(Chinese Academy of Sciences), Lili Wu(Chinese Academy of Sciences), Dan Lu(Chinese Academy of Sciences), Zhimin Liu(University of Tennessee Health Science Center), Xinxin Yan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Chai(Chinese Academy of Sciences)
Cited by 8
Related Papers
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|Science|2013|1.2k
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth
|Immunity|2016|397